Delivery Order SPE2DB20D3303-SPE2DB26FY2M5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $2,964.57. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is expected to be completed by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, valued at $36,969.40. This firm fixed-price contract, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) valued at $4,586.12. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 90, valued at $1,118.65 under a firm fixed-price contract. This non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. As a child contract action, this award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30 count) with a contract ceiling value of $5,618.72. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Terbinafine HCL 250 mg tablets (30-count) with a ceiling value of $1,547.58. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets, with a ceiling value of $4,397.88. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2M5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for Terbinafine HCL 250 mg tablets in a quantity of 90 units, with a ceiling value of $2,974.16. This firm fixed-price delivery order, which is scheduled for completion by November 10, 2025, represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds extensive federal contract portfolio with the Defense Logistics Agency covering diverse therapeutic categories including specialty medications, generic and brand-name drugs, vaccines, and medical supplies. The company's federal contracting history demonstrates consistent capability to fulfill open competition requirements across delivery orders ranging from small-value transactions to substantial orders, supporting critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/7/25 |